TMCnet News

OTCtipReporter.com: Bio-AMD, Inc. (OTCBB: BIAD), Augme Technologies, Inc. (OTCBB: AUGT): Sign up for our FREE Stock Picks Today!
[December 12, 2011]

OTCtipReporter.com: Bio-AMD, Inc. (OTCBB: BIAD), Augme Technologies, Inc. (OTCBB: AUGT): Sign up for our FREE Stock Picks Today!


(M2 PressWIRE Via Acquire Media NewsEdge) Join us at www.OTCtipReporter.com for a complimentary subscription to the most exciting online financial newsletter.

___________________________________________________________________________ Find out the Buzz on all the Hottest stocks at: http://www.OTCtipReporter.com Bio-AMD, Inc.; Legal Action Settled LONDON, Dec. 8, 2011 -- Bio-AMD, Inc. ("Bio-AMD" or the "Company) (OTCBB: BIAD) today announces settlement of a claim against its former legal counsel.



The Company is pleased to have satisfactorily settled its claim prior to a timetabled court hearing in 2012 which would otherwise have resulted in further cost, distraction and risk to its business. The Company now looks forward to further progressing its core medical diagnostic device operations.

About Bio-AMD, Inc.


Bio-AMD has two majority owned UK subsidiaries: Bio-AMD Limited, a technology developer for medical diagnostic devices; and the WDX Organisation Ltd, the owner of the Wocu(TM), a global currency data reference source for application in financial markets. (www.wocu.com).

To find out more about Bio-AMD (OTCBB: BIAD), visit our websites at www.bioamd.com.

Forward-Looking Statements Statements in this news release that are not statements of historical fact are forward-looking statements, which are subject to certain risks and uncertainties. Forward-looking statements can often be identified by words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Actual results may differ materially from those expressed or implied by forward-looking statements due to a variety of factors that may or may not be foreseeable or within the reasonable control of the Company. Readers are cautioned not to place undue reliance on such forward-looking statements. Additional information on risks and other factors that may affect the business and financial results of the Company can be found in filings of the Company with the U.S. Securities and Exchange Commission, including without limitation under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2010 filed on March 23, 2011. Except as otherwise required by law, the Company disclaims any obligations or undertaking to publicly release any updates or revisions to any forward-looking statement contained in this news release to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

___________________________________________________________________________ Visit www.OTCtipReporter.com Jeff Jaffrey Joins Augme Technologies' Advisory Board International Investor to Play Key Advisory Role NEW YORK, NY -- 12/09/11 -- Augme Technologies, Inc. (OTCBB: AUGT), ("Augme") ("the Company") a technology and services leader in interactive media marketing that offers the only patented and innovative end-to-end mobile marketing platform, today announced that international investor Jeff Jaffrey has joined the Company's Advisory Board.

Mr. Jaffrey is a partner of Veritas Investments. He launched the Veritas I fund in 2008 and is currently invested in nine businesses, ranging from forestry to the medical device industries. He has participated in multiple transactions with some of the world's largest pharmaceutical companies and has also been instrumental in helping large biotech firms to develop effective distribution platforms in the Middle East.

Mr. Jaffrey's has long-standing relationships with high-net-worth individuals, key business and political leaders, institutions and sovereign funds. His expertise lies in utilizing his contact base to assist companies in the identification of revenue opportunities, entry into new markets, the selection of strategic partners and/or the acquisition of new licenses/contracts.

Mr. Jaffrey began his career in 2004 at Barclays Private Bank in Geneva, Switzerland. From 2006 until 2010, he held management positions at two Geneva-based private equity firms. He and a consortium of families, private individuals, banks and hedge funds, have invested significant dollars on a global basis. From 2006 until 2008, Mr. Jaffrey was also a founding partner of Tactica Switzerland, a private fund managed by the Internal Strategies Group within Goldman Sachs.

"Augme is strategically positioned at the forefront of mobile marketing innovation and execution," Mr. Jaffrey said. "I am pleased to be able to lend my expertise and relationships to drive the business forward at an aggressive pace." "We are very pleased that Jeff has joined our Advisory Board," noted Ivan Braiker, President of Augme Technologies, Inc. "We believe he can contribute to the achievement of our corporate objectives by identifying and facilitating potential strategic partnerships and by providing valuable counsel regarding a broad range of financial and business initiatives." About Augme Technologies, Inc.

Augme Technologies, Inc. (OTCBB: AUGT) provides strategic services and mobile marketing technology to leading consumer and healthcare brands. Its platforms, including AD LIFE(TM), have provided measurable successes across an industry-leading 130,000+ campaigns for such clients as Macy's, MillerCoors, Nestle, KFC, and Clear Channel. Augme's offerings allow marketers, brands, and agencies to plan, create, test, deploy, and track mobile marketing programs across every mobile channel, including SMS, 2D/QR codes, mobile websites, advertising networks, social media and branded apps. Augme's platforms facilitate consumer brand interaction and the ability to track and analyze campaign results. Using its own patented device-detection and proprietary mobile content adaptation software, AD LIFE(TM) solves the mobile marketing industry problem of disparate operating systems, device types, and on-screen mobile content rendering. Augme also provides business-to-consumer solutions, including national mobile couponing campaigns, strategic mobile healthcare tools, custom mobile application development, and consumer data tracking and analytics. In addition to AD LIFE(TM), Augme acquired the assets of Hipcricket, Inc. and Jagtag, Inc. and licenses the digital broadcast platform BOOMBOX. Augme is headquartered in New York City, with operations in Seattle, Atlanta, Dallas, Los Angeles, Chicago, Tucson and San Francisco. For more information, visit www.augme.com.

Augme Technologies, Inc.(TM), Augme(TM), AD LIFE(TM), BOOMBOX, AD SERVE(TM) and the Augme logo are trademarks of Augme Technologies, Inc. All rights reserved. 2009-11.

Forward-Looking Statements This release includes forward-looking statements. All statements regarding our expected future financial position, including management's revenue guidance, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in Augme's Form 10-K for the year ended February 28, 2011 and more recent reports and registration statements filed with the SEC.Augme Technologies, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter such forward-looking statements, whether as a result of new information, future events or otherwise.

___________________________________________________________________________ Visit www.OTCtipReporter.com Also, you can receive up to the minute stock alerts via our Twitter page: http://twitter.com/#!/OTCtipReporter Get the BUZZ on all of Wall Street's Hottest stocks Free! About OTCtipReporter.com OTCtipReporter.com alerts investors to promising small cap companies, many (if not all) are overlooked by your run of the mill Wall Street investment advisors. At OTCtipReporter.com, we know it is easier to find a stock that can go from $0.01 - $0.50 in days or weeks, than it is to find a stock that can go from $1.00 - $50.00 in months or years. OTCtipReporter.com provides its subscribers with comprehensive public information and due diligence for small companies with huge potential. While many of the other investment newsletters talk a big game, at OtctipReporter.com we let our research do the talking! We invite you to give us a try and sign up for free today at: http://www.OTCtipReporter.com We do the Research, You Reap The Profits.

We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by OTC Tip Reporter. Please be advised that the information provided May or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed. OTC Tip Reporter is not responsible for any content issued in this press release. Individuals should assume that all information contained here is not trustworthy unless verified by their own independent research. To view a complete disclaimer, visit: http://www.otctipreporter.com/disclaimer.htm Let OTC Tip Reporter help advertise for your company using our effective awareness campaigns. If you're Interested in telling your story, we can help. Contact us at [email protected] To feature your publicly traded company in our alerts, email us at: [email protected] CONTACT: CONTACT: OTC Tip Reporter Tel: +1 347 829 7044 e-mail: [email protected] WWW: http://www.OTCtipReporter.com ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected])).

(c) 2011 M2 COMMUNICATIONS

[ Back To TMCnet.com's Homepage ]